Abstract
Axillary dissection has been considered essential for breast cancer staging because nodal metastasis is the most powerful predictive factor for recurrence. On the other hand, morbidity, such as lymphedema and shoulder dysfunction, may occur. Sentinel node biopsy is a good way to avoid unnecessary axillary dissection. We used tin colloid as a carrier of Tc99m tracer together with the blue dye method. The detection rate of the sentinel node was 27 cases out of 29 (90%) for the blue dye method, 10 cases out of 19 (53%) for the Rl method, and 27 out of 33 (82%) for the combined method. The detection rate of the Rl method was improved after adding the subcutaneous injection over the tumor from 45% before adding the subcutaneous injection to 82% after adding it. The false negative rate was 11% for the blue dye method, 0% for the R1 method, and 10% for the combined method. This yields a sensitivity of 89% for the blue dye method, 100% for the R1 method, and 90% for the combined method. Specificity was 100% for all three methods. Accuracy was 96% for the blue dye method, 100% for the R1 method, and 96% for the combined method. There were two false negative cases. The average number of sentinel lymph nodes was 2.12 for the dye method, 1.66 for the R1 method, and 1.95 for the combined method. There were three of 49 cases with identified parasternal lymph nodes by R1 imaging. Lymphatic mapping using tin colloid may be useful for detecting sentinel nodes.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Monica Morrow: Management of the axillary nodes.Breast Cancer, 6:1–12, 1999.
Ikeda T: A sentinel node biopsy in breast cancer patients. Editorial,Surg Today (Jpn J Surg), 29:197–199, 1999.
Hiram S Cody: Sentinel lymph node mapping in breast cancer.Breast Cancer 6:13–22, 1999.
Ikeda T, Masamura S, Matsui A,et al: Problems and perspectives in the treatment of breast cancer patients upon 21st century- pros and cons of axillary dissection.Mamma, 34:1–6, 1999. (in Japanese)
Krag DN, Weaver DL, Alex C,et al: Surgical resection and radio-localization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–340, 1993.
Veronesi U: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series.J Natl Cancer Inst 91:368–373, 1999.
Giuliano AE, Jones RC, Brennan M,et al: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997.
Cox CE, Pendas S, Cox JM,et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.
Wilhelm AJ, Mijnhout GS, Franssen EJF: Radiopharmaceuticals in sentinel lymph-node detec-tion-an overview.Eur J Nuclear Med 26:S36-S42, 1999.
Sato K, Uematsu M, Saito T,et al: Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloids.Breast Cancer 7:95–98, 2000.
Imoto S, Murakami K, Ikeda H,et al: Mammary lyphoscintigraphy with various radiopharmaceuticals in breast cancer.Ann Nucl Med 13:325–329, 1999.
Author information
Authors and Affiliations
About this article
Cite this article
Ikeda, T., Masamura, S., Fujii, H. et al. Sentinel lymph node biopsy using tin colloid Rl and blue dye method. Breast Cancer 7, 284–286 (2000). https://doi.org/10.1007/BF02966391
Issue Date:
DOI: https://doi.org/10.1007/BF02966391